ArticleBritish journal of cancer2001
CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation.
Article in British journal of cancer, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
39 citing papers in PubMed, 132 citations in OpenAlex.
- Novel Paired Normal Prostate and Prostate Cancer Model Cell Systems Derived from African American Patients.Cancer research communications · 2022Article
- Hypoxia-induced nitric oxide release by luminal cells stimulates proliferation and uPA secretion of myoepithelial cells in a bicellular murine mammary tumor.Journal of cancer research and clinical oncology · 2015Article
- Transforming growth factor-β, insulin-like growth factor I/insulin-like growth factor I receptor and vascular endothelial growth factor-A: prognostic and predictive markers in triple-negative and non-triple-negative breast cancer.Molecular medicine reports · 2015Article
- Basaloid carcinoma of the pancreas--clinicopathological presentation and oncogenetic snapshot of a rare entity.Virchows Archiv : an international journal of pathology · 2015Article
- Article
- Differential expression of lipid metabolism-related proteins in different breast cancer subtypes.PloS one · 2015Article
- Origin and differentiation of breast nipple syringoma.Scientific reports · 2012Article
- Statistical association of basal cell keratins with metastasis-inducing proteins in a prognostically unfavorable group of sporadic breast cancers.The American journal of pathology · 2011Article
- Maspin expression is frequent and correlates with basal markers in triple-negative breast cancer.Diagnostic pathology · 2011Article
- D2-40: an additional marker for myoepithelial cells of breast and the precaution in interpreting tumor lymphovascular invasion.International journal of clinical and experimental pathology · 2011Article
- Androgen receptor is frequently expressed in HER2-positive, ER/PR-negative breast cancers.Virchows Archiv : an international journal of pathology · 2010Article
- Molecular therapy of breast cancer: progress and future directions.Nature reviews. Endocrinology · 2010Review
- Clinicopathological features and treatment strategy for triple-negative breast cancer.International journal of clinical oncology · 2010Article
- The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy.British journal of cancer · 2009Article
- Demystifying basal-like breast carcinomas.Journal of clinical pathology · 2007Review
- Paradoxical antiproliferative effect by a murine mammary tumor-derived epithelial cell line.BMC cancer · 2007Article
- Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas.Journal of clinical pathology · 2007Article
- Use of immunohistochemical markers can refine prognosis in triple negative breast cancer.BMC cancer · 2007Article
- Breast cancer clinical and translational research: analogies and implications for prostate cancer.Reviews in urology · 2007Article
- Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival.Breast cancer research : BCR · 2007Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 4 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
2-18% of ductal carcinoma-No Special Type (NST) are reported to express basal cell keratin 14 and such tumours may have a different metastatic pattern and prognosis. We performed immunohistochemistry for cytokeratins 19 (luminal) and 14 (basal) on 92 ductal carcinoma-NST. Those tumours showing CK14 expression were further characterized by immunohistochemistry for myoepithelial cell phenotype and analysed by comparative genomic hybridization. The 7 cases of ductal carcinoma-NST exhibiting a basal cell phenotype were all grade III tumours and showed a molecular cytogenetic profile similar to more conventional myoepithelial cell carcinomas. Therefore it appears that grade III invasive ductal carcinomas contain a subset of tumours with specific morphological and cytogenetic characteristics, and probably prognosis for the patient.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.